Funding Rounds
EpilepsyGTx

EpilepsyGTx Seed (2024, $10M)

EpilepsyGTx

Developer of gene therapies to treat focal refractory epilepsy.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $10.00M

Investors